| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |